The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Harvard Bioscience Inc

Nasdaq: HBIO
Last

(U.S.) $2.45

Today's change0.00 0.00%
Updated April 24 12:08 PM -4GMT. Delayed by at least 15 minutes.
 

Harvard Bioscience Inc

Nasdaq: HBIO
Last

(U.S.) $2.45

Today's change0.00 0.00%
Updated April 24 12:08 PM -4GMT. Delayed by at least 15 minutes.

Harvard Bioscience Inc unchanged

Harvard Bioscience Inc is unchanged today sitting at (U.S.)$2.45. Over the last five days, shares have gained 2.08%, but are down 19.67% for the last year to date. Shares have underperformed the S&P 500 by 34.85% during the last year.

Key company metrics

  • Open(U.S.) $2.45
  • Previous close(U.S.) $2.45
  • High(U.S.) $2.50
  • Low(U.S.) $2.45
  • Bid / Ask(U.S.) $2.45 / (U.S.) $2.50
  • YTD % change-19.67%
  • Volume21,674
  • Average volume (10-day)147,963
  • Average volume (1-month)115,569
  • Average volume (3-month)75,311
  • 52-week range(U.S.) $2.25 to (U.S.) $3.90
  • Beta1.22
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward15.31×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.13
Updated April 24 12:08 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.82%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue26252627
Total other revenue--------
Total revenue26252627
Gross profit12121213
Total cost of revenue14131414
Total operating expense28262727
Selling / general / administrative10101011
Research & development1121
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)1100
Other operating expenses, total--------
Operating income-1-1-10
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-1-10
Income after tax-1-2-1-1
Income tax, total0100
Net income-1-2-1-1
Total adjustments to net income--------
Net income before extra. items-1-2-1-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-2-1-1
Inc. avail. to common incl. extra. items-1-2-1-1
Diluted net income-1-2-1-1
Dilution adjustment--------
Diluted weighted average shares34343434
Diluted EPS excluding extraordinary itemsvalue per share-0.04-0.05-0.02-0.02
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.02-0.04-0.02-0.02